Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 2nd October 2012
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel
Update on Bluetongue vaccination
Regulation change for Bluetongue-free areas

Bluetongue laws have changed for England and Scotland, and are set to change for Wales, to allow the use of approved inactivated vaccines in Bluetongue-free areas, on the basis of Veterinary Risk Assessments.

In England, the Bluetongue (Amendment) Regulations 2012 came into effect last month (24 August) to permit the use of inactivated Bluetongue vaccines in Bluetongue-free areas. A General Licence has been issued to protect against Bluetongue serotypes 1, 2, 4 and 8.

Scotland's Bluetongue (Scotland) Order 2012 came into effect at the same time as England and permits inactivated Bluetongue vaccinations against all serotypes within Bluetongue-free areas.

Next week (10 October), the Bluetongue (Wales) (Amendment) Regulations 2012 will come into effect, permitting the use of inactivated Bluetongue vaccinations in Bluetongue-free areas against all serotypes.

The use of voluntary vaccination against Bluetongue remain illegal in both Northern Ireland and the Republic of Ireland.

Regulations for live attenuated vaccines remain unaltered, and must not be used due to the risk of reversion to virulence and subsequent disease spread. Live attenuated vaccines do not have marketing authorisations for use in the UK.

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.